Herbas VPB

Print
EN | LT
LT - COMBINATION THERAPY OF ANTIBODIES ACTIVATING HUMAN CD40 AND ANTIBODIES AGAINST HUMAN PD-L1
EN - COMBINATION THERAPY OF ANTIBODIES ACTIVATING HUMAN CD40 AND ANTIBODIES AGAINST HUMAN PD-L1

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/28
A61K 39/00
C07K 16/24
European patent
(11) Number of the document 3180357
(13) Kind of document T
(96) European patent application number 15748249.8
Date of filing the European patent application 2015-08-11
(97) Date of publication of the European application 2017-06-21
(45) Date of publication and mention of the grant of the patent 2019-07-03
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/EP2015/068404
Date 2015-08-11
PCT application publication
(87) Number WO 2016/023875
Date 2016-02-18
Priority applications
(30) Number Date Country code
14181067 2014-08-14 EP
15159611 2015-03-18 EP
Inventors
(72)
CORSE, Emily Rana, CH
FREYTAG, Olivier, CH
GERDES, Christian, CH
LE CLECH, Marine, CH
LEVITSKY, Hyam, US
OTT, Marion, CH
STERN, Martin, CH
WEI, Xu, CH
Grantee
(73) F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel, CH
Title
(54) COMBINATION THERAPY OF ANTIBODIES ACTIVATING HUMAN CD40 AND ANTIBODIES AGAINST HUMAN PD-L1
  COMBINATION THERAPY OF ANTIBODIES ACTIVATING HUMAN CD40 AND ANTIBODIES AGAINST HUMAN PD-L1
Last update date 2021-04-30